Supply chain attack

Aurisco Expands Oligonucleotide Capacity and Launches New Website

Retrieved on: 
Friday, April 21, 2023

SETÚBAL, Portugal, April 20, 2023 /PRNewswire/ -- On its 25th anniversary, Aurisco Pharmaceutical, an innovative pharmaceutical CRDMO (contract research, development and manufacturing organization) announced the expansion of its oligonucleotide manufacturing capacity and a new edition of its corporate website – www.aurisco.com

Key Points: 
  • The New State-of-Art OligoPilot 2000™ solid-phase synthesizer adds cGMP manufacturing capacity to support and accelerate clinical and commercial oligonucleotide programs.
  • SETÚBAL, Portugal, April 20, 2023 /PRNewswire/ -- On its 25th anniversary, Aurisco Pharmaceutical, an innovative pharmaceutical CRDMO (contract research, development and manufacturing organization) announced the expansion of its oligonucleotide manufacturing capacity and a new edition of its corporate website – www.aurisco.com .
  • The new OligoPilot 2000™ solid-phase synthesizer, from Cytiva, completes Aurisco Biotech's pilot scale cGMP plant and provides immediate capacity availability to accelerate customer's clinical programs as well as Aurisco's generic oligonucleotide pipeline.
  • The new website has been designed to offer a more user-friendly experience with more information, improved navigation and new communication functionalities.

Aurisco Expands Oligonucleotide Capacity and Launches New Website

Retrieved on: 
Friday, April 21, 2023

SETÚBAL, Portugal, April 20, 2023 /PRNewswire/ -- On its 25th anniversary, Aurisco Pharmaceutical, an innovative pharmaceutical CRDMO (contract research, development and manufacturing organization) announced the expansion of its oligonucleotide manufacturing capacity and a new edition of its corporate website – www.aurisco.com

Key Points: 
  • The New State-of-Art OligoPilot 2000™ solid-phase synthesizer adds cGMP manufacturing capacity to support and accelerate clinical and commercial oligonucleotide programs.
  • SETÚBAL, Portugal, April 20, 2023 /PRNewswire/ -- On its 25th anniversary, Aurisco Pharmaceutical, an innovative pharmaceutical CRDMO (contract research, development and manufacturing organization) announced the expansion of its oligonucleotide manufacturing capacity and a new edition of its corporate website – www.aurisco.com .
  • The new OligoPilot 2000™ solid-phase synthesizer, from Cytiva, completes Aurisco Biotech's pilot scale cGMP plant and provides immediate capacity availability to accelerate customer's clinical programs as well as Aurisco's generic oligonucleotide pipeline.
  • The new website has been designed to offer a more user-friendly experience with more information, improved navigation and new communication functionalities.

Aurisco Expands Oligonucleotide Capacity and Launches New Website

Retrieved on: 
Friday, April 21, 2023

SETÚBAL, Portugal, April 20, 2023 /PRNewswire/ -- On its 25th anniversary, Aurisco Pharmaceutical, an innovative pharmaceutical CRDMO (contract research, development and manufacturing organization) announced the expansion of its oligonucleotide manufacturing capacity and a new edition of its corporate website – www.aurisco.com

Key Points: 
  • The New State-of-Art OligoPilot 2000™ solid-phase synthesizer adds cGMP manufacturing capacity to support and accelerate clinical and commercial oligonucleotide programs.
  • SETÚBAL, Portugal, April 20, 2023 /PRNewswire/ -- On its 25th anniversary, Aurisco Pharmaceutical, an innovative pharmaceutical CRDMO (contract research, development and manufacturing organization) announced the expansion of its oligonucleotide manufacturing capacity and a new edition of its corporate website – www.aurisco.com .
  • The new OligoPilot 2000™ solid-phase synthesizer, from Cytiva, completes Aurisco Biotech's pilot scale cGMP plant and provides immediate capacity availability to accelerate customer's clinical programs as well as Aurisco's generic oligonucleotide pipeline.
  • The new website has been designed to offer a more user-friendly experience with more information, improved navigation and new communication functionalities.

Aurisco Expands Oligonucleotide Capacity and Launches New Website

Retrieved on: 
Thursday, April 20, 2023

SETÚBAL, Portugal, April 20, 2023 /PRNewswire/ -- On its 25th anniversary, Aurisco Pharmaceutical, an innovative pharmaceutical CRDMO (contract research, development and manufacturing organization) announced the expansion of its oligonucleotide manufacturing capacity and a new edition of its corporate website – www.aurisco.com

Key Points: 
  • The New State-of-Art OligoPilot 2000TM solid-phase synthesizer adds cGMP manufacturing capacity to support and accelerate clinical and commercial oligonucleotide programs.
  • SETÚBAL, Portugal, April 20, 2023 /PRNewswire/ -- On its 25th anniversary, Aurisco Pharmaceutical, an innovative pharmaceutical CRDMO (contract research, development and manufacturing organization) announced the expansion of its oligonucleotide manufacturing capacity and a new edition of its corporate website – www.aurisco.com .
  • The new OligoPilot 2000TM solid-phase synthesizer, from Cytiva, completes Aurisco Biotech's pilot scale cGMP plant and provides immediate capacity availability to accelerate customer's clinical programs as well as Aurisco's generic oligonucleotide pipeline.
  • The new website has been designed to offer a more user-friendly experience with more information, improved navigation and new communication functionalities.

Aurisco Expands Oligonucleotide Capacity and Launches New Website

Retrieved on: 
Thursday, April 20, 2023

SETÚBAL, Portugal, April 20, 2023 /PRNewswire/ -- On its 25th anniversary, Aurisco Pharmaceutical, an innovative pharmaceutical CRDMO (contract research, development and manufacturing organization) announced the expansion of its oligonucleotide manufacturing capacity and a new edition of its corporate website – www.aurisco.com

Key Points: 
  • The New State-of-Art OligoPilot 2000TM solid-phase synthesizer adds cGMP manufacturing capacity to support and accelerate clinical and commercial oligonucleotide programs.
  • SETÚBAL, Portugal, April 20, 2023 /PRNewswire/ -- On its 25th anniversary, Aurisco Pharmaceutical, an innovative pharmaceutical CRDMO (contract research, development and manufacturing organization) announced the expansion of its oligonucleotide manufacturing capacity and a new edition of its corporate website – www.aurisco.com .
  • The new OligoPilot 2000TM solid-phase synthesizer, from Cytiva, completes Aurisco Biotech's pilot scale cGMP plant and provides immediate capacity availability to accelerate customer's clinical programs as well as Aurisco's generic oligonucleotide pipeline.
  • The new website has been designed to offer a more user-friendly experience with more information, improved navigation and new communication functionalities.

Apiiro to Present on Design-Level Software Supply Chain Threats at LASCON 2022

Retrieved on: 
Wednesday, September 28, 2022

TEL AVIV, Israel and NEW YORK, Sept. 28, 2022 /PRNewswire/ -- Apiiro , the leader in Cloud-Native Application Security, today announced that Vice President of Security Research, Moshe Zioni, will present at The Lonestar Application Security Conference 2022 (LASCON) in Austin, TX.

Key Points: 
  • TEL AVIV, Israel and NEW YORK, Sept. 28, 2022 /PRNewswire/ -- Apiiro , the leader in Cloud-Native Application Security, today announced that Vice President of Security Research, Moshe Zioni, will present at The Lonestar Application Security Conference 2022 (LASCON) in Austin, TX.
  • What: Zioni's session titled "Design-Level Supply Chain Attacks in the Real World" will address why design-originated weaknesses are the biggest threat to software supply chain security and what steps organizations can take to minimize risk.
  • Where: Cypress Room at Norris Conference Centers in Austin, TX
    LASCON is an OWASP -associated annual conference that gathers web app developers, security engineers, mobile developers and information security professionals to share curing-edge ideas, initiatives and technology advancements.
  • Apiiro is a platinum sponsor and attendees will have the opportunity to meet with executives at booth #21 to discuss how its technology is enabling security teams and developers to proactively fix critical risks in the software supply chain.

Black Hat USA Research: Supply Chain and Cloud Security Risks Are Top of Mind

Retrieved on: 
Wednesday, August 3, 2022

Black Hat , the producer of the cybersecurity industrys most established and in-depth security events, releases its eighth annual community survey Supply Chain and Cloud Security Risks Are Top of Mind.

Key Points: 
  • Black Hat , the producer of the cybersecurity industrys most established and in-depth security events, releases its eighth annual community survey Supply Chain and Cloud Security Risks Are Top of Mind.
  • 2021 was the year of supply chain attacks as organizations learned the various ways the global supply chain could be abused to compromise a large number of victims.
  • To learn more about these research results, download a copy of Supply Chain and Cloud Security Risks Are Top of Mind here: https://messages.blackhat.com/2022-attendee-report-2022 .
  • For over 20 years, Black Hat has provided attendees with the very latest in information security research, development, and trends.

Nintendo Unveils Xenoblade Chronicles 3 Direct Presentation Packed With New Footage and Details

Retrieved on: 
Wednesday, June 22, 2022

In a new Xenoblade Chronicles 3 Direct video presentation today, Nintendo unveiled nearly 25 minutes of new footage featuring monstrous foes, intriguing personalities and sweeping locales from the upcoming game.

Key Points: 
  • In a new Xenoblade Chronicles 3 Direct video presentation today, Nintendo unveiled nearly 25 minutes of new footage featuring monstrous foes, intriguing personalities and sweeping locales from the upcoming game.
  • To view the Xenoblade Chronicles 3 Direct video in its entirety, visit Nintendos YouTube channel .
  • View the full release here: https://www.businesswire.com/news/home/20220622005383/en/
    In a new Xenoblade Chronicles 3 Direct video presentation today, Nintendo unveiled nearly 25 minutes of new footage featuring monstrous foes, intriguing personalities and sweeping locales from the upcoming game.
  • (Graphic: Business Wire)
    As the latest entry in the critically acclaimed role-playing series, Xenoblade Chronicles 3 connects the futures of the two previous mainline Xenoblade Chronicles games.

STANLEY Security Releases 2022 Industry Trends Report

Retrieved on: 
Wednesday, January 19, 2022

INDIANAPOLIS, Jan. 19, 2022 /PRNewswire/ -- STANLEY Security has today released its third annual Industry Trends Report, revealing the key themes that industry leaders expect will shape the security industry in 2022 and beyond.

Key Points: 
  • INDIANAPOLIS, Jan. 19, 2022 /PRNewswire/ -- STANLEY Security has today released its third annual Industry Trends Report, revealing the key themes that industry leaders expect will shape the security industry in 2022 and beyond.
  • "The STANLEY Security 2022 Industry Trends Report focuses on just that how technology and the insights it provides can empower businesses.
  • Two key trends of note that STANLEY Security predicts for 2022 include Navigating the Future of the Workplace and an 'Always-on' Approach to Security.
  • In the Industry Trends Report, STANLEY Security predicts Advancing the Era of Automationto be a key trend for 2022.

HP Earns Distinguished Certification for Supply Chain Security

Retrieved on: 
Thursday, October 7, 2021

PALO ALTO, Calif., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Today, in celebration of Cybersecurity Awareness Month (U.S.), HP Inc. announced its enterprise printers and Original HP cartridges are now ISO/IEC 20243 certified. Granted by The Open Group, the ISO/IEC 20243 standard is a set of requirements and recommendations for mitigating maliciously tainted and counterfeit products. By earning this certification, HP is ensuring its enterprise printers and Original HP cartridges follow best practices for global supply chain security throughout the product lifecycle.2

Key Points: 
  • By earning this certification, HP is ensuring its enterprise printers and Original HP cartridges follow best practices for global supply chain security throughout the product lifecycle.2
    The shift to hybrid work models is creating new, emerging and more frequent threats.
  • With so many people now working from home, the security perimeter has extended well beyond the office, said Shivaun Albright, HP Chief Technologist for Print Security.
  • This certification also builds upon HP Wolf Security announced in May 2021, which is HPs integrated portfolio that offers secure-by-design printers, hardware-enforced endpoint security software, and endpoint security services.
  • For more information on the growing industry-wide significance of the ISO/IEC 20243 certification to help assure product integrity and supply chain security, see white paper Protecting Print Systems: HP Print ISO 20243 Certification Extends Security into the Supply Chain from Keypoint Intelligence.